Filter Results:
(1,142)
Show Results For
- All HBS Web
(1,142)
- People (1)
- News (316)
- Research (705)
- Events (5)
- Multimedia (14)
- Faculty Publications (418)
Show Results For
- All HBS Web
(1,142)
- People (1)
- News (316)
- Research (705)
- Events (5)
- Multimedia (14)
- Faculty Publications (418)
- 01 Jun 2023
- News
Research Brief: The Best Medicine
the clinical approval process. In a survey experiment, the researchers found that 72 percent of doctors had been asked by their patients whether a new drug would “work in people like me.” Black patients and the doctors who treat them put... View Details
- December 2014 (Revised August 2015)
- Case
Improving Melanoma Screening: MELA Sciences
By: Regina E. Herzlinger, Kevin Schulman and Frédéric Dijols
MELA is a start-up medical device company looking to develop a novel technology to help physicians diagnose a deadly skin cancer, melanoma. The case reviews the FDA medical device development process, the development path pursued by MELA, and the regulatory and... View Details
- February 2007 (Revised June 2009)
- Case
Edelnor (A)
By: Jordan I. Siegel
Fernando del Sol, president of F. S. Inversiones in Chile, had just bought himself a headache as a New Year's present. On December 31, 2001, he purchased a Chilean electricity generation and transmission company called Edelnor that was in danger of becoming insolvent... View Details
Keywords: Restructuring; Insolvency and Bankruptcy; Investment; Courts and Trials; Business Strategy; Energy Industry; Chile
Siegel, Jordan I. "Edelnor (A)." Harvard Business School Case 707-473, February 2007. (Revised June 2009.)
- 16 Sep 2016
- News
Gaining Ground on ALS
Bucket Challenge to support the Phase 3 trial of a promising investigational drug that is designed to slow the loss of lung function and muscle strength in patients with ALS. “Clinical View Details
- 24 Sep 2020
- News
The Race for a Vaccine
proteins were created inside the human body. The company launched its first vaccine trial for a strain of avian influenza in 2015. If developing vaccines for widespread and endemic diseases has long been... View Details
- 2003
- Chapter
La tragédie de la thalidomide: affaires judiciaries et résponses législatives, 1959-1971
By: Arthur A. Daemmrich
- January 2008
- Supplement
Joe Bachelder: Reflections
By: Brian Hall and James K. Sebenius
After Charles Suarez's failed compensation negotiations with Victor, Suarez's attorney, Joe Batchelder, joined class discussions of the case in a course taught by Professor Brian Hall. Professor James Sebenius also interviewed Joe Bachelder at length on this case and... View Details
- 15 Jan 2018
- News
A Better Business Model for Fighting Cancer
- February 2020
- Supplement
Theranos: Who Has Blood on Their Hands? (B)
By: Nien-he Hsieh, Christina R. Wing and John Masko
This supplemental case tracks the results of the Colman and Taubman-Dye class action suit against Theranos as well as Theranos’ other legal challenges and chronicles the final demise of the company in 2019. View Details
Keywords: Health Testing and Trials; Corporate Accountability; Organizational Culture; Misleading and Fraudulent Advertising; Crime and Corruption; Entrepreneurship; Lawsuits and Litigation; Business Exit or Shutdown; Medical Devices and Supplies Industry; California; United States
Hsieh, Nien-he, Christina R. Wing, and John Masko. "Theranos: Who Has Blood on Their Hands? (B)." Harvard Business School Supplement 320-091, February 2020.
- September 1991 (Revised August 1994)
- Background Note
Note on Pharmaceutical Industry Regulation
Traces the evolution of U.S. regulatory policy towards the pharmaceutical industry over the course of the twentieth century. A major theme is the steady shift away from a policy of 'let the buyer beware' to the creation of a complex and time-consuming review process,... View Details
Keywords: Safety; Industry Growth; Marketing; Research and Development; Health Testing and Trials; Economics; Pharmaceutical Industry; United States
Emmons, Willis M., III. "Note on Pharmaceutical Industry Regulation." Harvard Business School Background Note 792-002, September 1991. (Revised August 1994.)
- 26 Feb 2007
- Research & Ideas
The Power of the Noncompete Clause
have rejected Microsoft's claims, Microsoft and Google settled out of court regarding Google's hiring Microsoft executive Kai-Fu Lee to head Google China. And the following... View Details
Keywords: by Martha Lagace
- 16 Mar 2022
- Blog Post
Taking Your Shot in the Sports Industry with Adam Laitsas (MBA 2016), SVP, Head of Marketing for Madison Square Garden Sports
Three months into his new role as SVP, Head of Marketing at Madison Square Garden Sports (MSG), Adam Laitsas (MBA 2016) looked out from his office onto a place that is equal parts inspiring and familiar. For three years, Laitsas regularly... View Details
- March 30, 2020
- Article
Why Is the U.S. Behind on Coronavirus Testing?
By: Stefan Thomke
Coronavirus testing is needed to address the uncertainty in making decisions about patient treatment, resource allocation, policy, and so much more. Answers to questions such as “When should we relax social distancing measures—and for whom?” or “How many ventilators... View Details
Keywords: Testing; Coronavirus; Culture; Trump; Data; Experiments; Health Pandemics; Health Testing and Trials; Government and Politics; United States
Thomke, Stefan. "Why Is the U.S. Behind on Coronavirus Testing?" Harvard Business Review Digital Articles (March 30, 2020).
- 01 Jun 2018
- News
Floor It
so that we can help get clinical trials done and move the pace of discovery even quicker.” How do they expect to get there? Here, a look at the accelerator’s model, which comprises four work streams, each... View Details
Keywords: Julia Hanna; illustration by Mengxin Li
- 22 Feb 2022
- News
Elevator Pitch: Good Vibrations
Illustration by Drue Wagner Illustration by Drue Wagner Bone Health Technologies Laura Yecies (MBA 1988), CEO Concept: OsteoBoost, a wearable vibration belt that is designed to treat osteopenia and prevent osteoporosis by reducing bone... View Details
- 23 Aug 2020
- News
In the UK, She Leads the Search for a COVID Vaccine
stop to the spread of COVID-19 was daunting. “When I told my daughter I wasn’t sure I could do this, she looked at me and said, ‘Mum! If I’d said that you’d have given me all this lip about ‘don’t be under-confident, you’re just putting... View Details
- 2009
- Case
Innovamedica: Innovation in an Emerging Market
By: Roberto Charvel, Fernando Fabre and T. Putimahtama
Innovamedica was a medical start up with several state of the art devices such as a silicon substitute heart and other inventions. However, the founding scientist was struggling in attracting talent and fundraising and that had an impact on growth. View Details
Keywords: Biotech; Entrepreneurial Finance; Entrepreneurship; Start-up; Emergent Countries; Business Startups; Talent and Talent Management; Design; Corporate Entrepreneurship; Private Equity; Health Testing and Trials; Innovation and Invention; Managerial Roles; Biotechnology Industry; Latin America; North and Central America
Charvel, Roberto, Fernando Fabre, and T. Putimahtama. "Innovamedica: Innovation in an Emerging Market." Instituto Panamericano de Alta Dirección de Empresa (IPADE) Case (P)DGe-440, 2009.
- June 2008 (Revised July 2008)
- Case
The Miami Project to Cure Paralysis
By: Robert Steven Kaplan, Christopher Marquis and Brent Kazan
Marc Buoniconti is the co-founder of the Miami Project to Cure Paralysis, a nonprofit medical research organization. The project was founded in 1985 by Marc and his father Nick, a former Hall of Fame football player, when Marc suffered a spinal cord injury. In 2007,... View Details
Keywords: Investment; Philanthropy and Charitable Giving; Health Testing and Trials; Leadership; Growth and Development Strategy; Mission and Purpose; Research and Development; Nonprofit Organizations; Health Industry; Miami
Kaplan, Robert Steven, Christopher Marquis, and Brent Kazan. "The Miami Project to Cure Paralysis." Harvard Business School Case 408-003, June 2008. (Revised July 2008.)
- 20 Sep 2021
- Blog Post
Taking Your Shot in the Sports Industry with Adam Laitsas (MBA 2016), SVP, Head of Marketing for Madison Square Garden Sports Corp.
Three months into his new role as SVP, Head of Marketing at Madison Square Garden Sports, Adam Laitsas (MBA 2016) looked out from his office onto a place that is equal parts inspiring and familiar. For three years, Laitsas regularly... View Details
- 13 Oct 2016
- News
Adding Muscle to the Fight Against Disease
afford these patients a better quality of life for a longer period of time. It could be the first new treatment for ALS in nearly 25 years and the first one to potentially affect muscle function and strength... View Details
Keywords: Deborah Blagg